HAE is Haemonetics Corporation (Healthcare) — a non-dividend-paying stock. Trading at $103.96. Market cap: $4.73B. Capital Quality Rank: 79/100 — Elite compounder.
Stock snapshot
| Price | $103.96 |
| Market cap | $4.73B |
| Sector | Healthcare |
| Exchange | NYQ |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 79 / 100 · Elite compounder |
| ROIC (TTM) | 7.0% |
| Revenue CAGR (3y) | 4.5% |
| Shareholder buyback yield | 7.13% |
| Altman Z-score zone | Grey |
About HAE
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Related non-dividend companies
Other non-dividend stocks investors research alongside HAE. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is HAE's current stock price?
HAE (Haemonetics Corporation) is currently trading at $103.96.
Does HAE pay a dividend?
HAE (Haemonetics Corporation) does not currently pay a regular dividend.
What is HAE's Capital Quality Rank?
HAE has a Capital Quality Rank of 79/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track HAE in DiviDrip
Add HAE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search HAE and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.
